Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018
Objective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated a...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2022-02-01
|
Series: | Salud Pública de México |
Subjects: | |
Online Access: | https://www.saludpublica.mx/index.php/spm/article/view/13210 |
_version_ | 1798000569815662592 |
---|---|
author | Paloma Muñoz-Aguirre Marta Zapata-Tarrés Priscilla Espinosa-Tamez Hugo Sánchez-Blas Marion Brochier Héctor Lamadrid-Figueroa |
author_facet | Paloma Muñoz-Aguirre Marta Zapata-Tarrés Priscilla Espinosa-Tamez Hugo Sánchez-Blas Marion Brochier Héctor Lamadrid-Figueroa |
author_sort | Paloma Muñoz-Aguirre |
collection | DOAJ |
description | Objective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated age-standardized national, state-level and health insurance mortality rates. We conducted a joinpoint regression analysis to describe mortality trends across the study period and estimate the average annual percent change (AAPC). Results. In a 20-year period, age-standardized ALL mortality rates increased from 1.6 per 100 000 in 1998 to 1.7 in 2018. Nationally, a constant annual increase in mortality was observed for both sexes (1998-2002 AAPC 0.6 in boys, and 1998-2002 AAPC 0.3 in girls). We observed heterogeneity in childhood ALL at a state level. Conclusion. Our results reflect the social, economic, geographic diversity of the country. Monitoring and surveillance of this disease is crucial to assess quality of care. |
first_indexed | 2024-04-11T11:22:25Z |
format | Article |
id | doaj.art-299371340d3b40a3b7bfaa52eb1dedc6 |
institution | Directory Open Access Journal |
issn | 0036-3634 |
language | English |
last_indexed | 2024-04-11T11:22:25Z |
publishDate | 2022-02-01 |
publisher | Instituto Nacional de Salud Pública |
record_format | Article |
series | Salud Pública de México |
spelling | doaj.art-299371340d3b40a3b7bfaa52eb1dedc62022-12-22T04:26:32ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36342022-02-01641263410.21149/1321012095Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018Paloma Muñoz-Aguirre0Marta Zapata-Tarrés1Priscilla Espinosa-Tamez2Hugo Sánchez-Blas3Marion Brochier4Héctor Lamadrid-Figueroa5Consejo Nacional de Ciencia y Tecnología. Mexico City, Mexico/Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCoordinación de Investigación, Fundación IMSS, A.C. Mexico City, MexicoUCSF Helen Diller Family Comprehensive Cancer Center, University of California. San Francisco, United StatesCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoCentro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, MexicoObjective. To determine the magnitude of mortality due to acute lymphoblastic leukemia (ALL) nationally and by age group, sex, state of residence and insurance status, as well as to evaluate time trends during the period 1998-2018 Materials and methods. We obtained ALL mortality data and estimated age-standardized national, state-level and health insurance mortality rates. We conducted a joinpoint regression analysis to describe mortality trends across the study period and estimate the average annual percent change (AAPC). Results. In a 20-year period, age-standardized ALL mortality rates increased from 1.6 per 100 000 in 1998 to 1.7 in 2018. Nationally, a constant annual increase in mortality was observed for both sexes (1998-2002 AAPC 0.6 in boys, and 1998-2002 AAPC 0.3 in girls). We observed heterogeneity in childhood ALL at a state level. Conclusion. Our results reflect the social, economic, geographic diversity of the country. Monitoring and surveillance of this disease is crucial to assess quality of care.https://www.saludpublica.mx/index.php/spm/article/view/13210mortalitychildhood cancerallleukemiamexicopediatric cancer |
spellingShingle | Paloma Muñoz-Aguirre Marta Zapata-Tarrés Priscilla Espinosa-Tamez Hugo Sánchez-Blas Marion Brochier Héctor Lamadrid-Figueroa Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 Salud Pública de México mortality childhood cancer all leukemia mexico pediatric cancer |
title | Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 |
title_full | Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 |
title_fullStr | Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 |
title_full_unstemmed | Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 |
title_short | Childhood acute lymphoblastic leukemia in Mexico: mortality trend analysis, 1998-2018 |
title_sort | childhood acute lymphoblastic leukemia in mexico mortality trend analysis 1998 2018 |
topic | mortality childhood cancer all leukemia mexico pediatric cancer |
url | https://www.saludpublica.mx/index.php/spm/article/view/13210 |
work_keys_str_mv | AT palomamunozaguirre childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 AT martazapatatarres childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 AT priscillaespinosatamez childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 AT hugosanchezblas childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 AT marionbrochier childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 AT hectorlamadridfigueroa childhoodacutelymphoblasticleukemiainmexicomortalitytrendanalysis19982018 |